Presentation, survival and prognostic markers in AA amyloidosis

We reviewed 43 patients with AA amyloidosis who presented to our unit betwe en 1985-1999: 70% had an underlying chronic rheumatological diagnosis. Medi an (95% CI) patient survival from time of diagnosis was 52.9 months (9.4-96 .6) and median renal survival was 18 months (3.2-32.8) Twenty-four patients have died; 42% of deaths were due to infection, while renal failure accoun ted for 12.5%. Presenting factors which adversely influenced outcome were a low serum albumin and a high 24-h urinary albumin excretion (p = 0.007 and p = 0.003, respectively). Stepwise multivariate regression analysis identi fied albuminuria and presenting creatinine clearance as significant predict ors. (p =0.005 and p = 0.035, respectively). Mean C-reactive protein (CRP) thuoughout follow-up correlated weakly but not significantly with survival off dialysis (p = 0.06). Change in creatinine clearance correlated with alb uminuria. (r(2) = 40%, p = 0.001).